OIS@ASCRS
Jonathan Norris, managing director, Silicon Valley Bank, compares Medtech financing to biopharma start-ups. The data on deals are interesting, showing distinct trends for both sectors.…
Read MoreAndrew Gitkin, head, West Coast biotechnology investment banking, Piper Jaffray, reviews the impact the Trump presidency is having on the public markets. He also hits…
Read MoreChuck Hess, vice president and general manager, US Surgical, Bausch & Lomb, says retina will play a significant role in the company’s growth going forward.…
Read MoreBrent Wilde, president, Minnesota Eye Consultants, shares the biggest challenges facing ophthalmology practices. He also discusses how eye care practices are handling consolidation in comparison…
Read MoreAndy Doraiswamy, former COO of Oculeve, explains how he came to play a key role in the development of Oculeve, the dry eye company acquired…
Read MoreAndrew Gitkin, head of West Coast biotechnology investment banking – Piper Jaffray, says ophthalmology start-ups stand to benefit from a “renaissance of information” that’s giving…
Read MoreAli Behbahani, MD, partner at NEA, outlines the “unique aspects” that make ophthalmology an interesting area for VCs to invest capital. He also explains what…
Read MoreRichard Lindstrom, MD, founder of Minnesota Eye Consultants, discusses his group’s partnership with Waud Capital to create a new national ophthalmology practice leader. Dr. Lindstrom…
Read MoreDavid Alpern, founding partner of Varsity Healthcare Partners, says the ophthalmology industry is due to run up against several financial and demographic challenges going forward.…
Read MoreRichard Lewis, MD, founder of Sacramento Eye Consultants, says the arrival of MIGS has completely changed how physicians can treat glaucoma. In this interview, Lewis…
Read MoreJerry St. Peter, VP & head, ophthalmic business, says the ophthalmology newcomer is making great progress in building broad pipeline to treat eye disease including…
Read MoreFrederic Guerard, worldwide business franchise head, ophthalmology, explains how the pharmaceutical giant came to make large bets in presbyopia and dry eye. “I’d like to…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.